Repository logo
 
Publication

Síndromes de Deficiência Cerebral de Creatina

dc.contributor.authorMalheiro, R
dc.contributor.authorDiogo, L
dc.contributor.authorGarcia, P
dc.contributor.authorFineza, I
dc.contributor.authorOliveira, G
dc.date.accessioned2013-03-20T15:20:04Z
dc.date.available2013-03-20T15:20:04Z
dc.date.issued2012
dc.description.abstractIntroduction: Creatine deficiency syndromes are a recently described group of diseases characterized by inborn errors of creatine metabolism. Clinical features include a spectrum of neurodevelopment disorders of diverse severity. They are characterized by low levels of cerebral creatine caused by different pathogenic mutations concerning the genes coding for creatine synthesis enzymes [arginine: glicyne amidinotransferase (AGAT, EC 2.1.4.1) and guanidinoacetate methyltansferase (GAMT, EC 2.1.1.2)], AGAT and GAMT, respectively, or its transporter (CT1 deficiency), SLC6A8. Enzymatic deficiencies are transmitted as autosomal recessive traits, whereas the transporter deficit is X-linked. Objectives: To characterize the clinical and laboratorial presentation, diagnosis and treatment of cerebral creatine deficiency patients, followed in Hospital Pediátrico Carmona da Mota. The awareness of these inborn errors of metabolism as neurological disorders, namely of neurodevelopment, among the medical community is a secondary aim of the present work. Methods and Material: Retrospective analysis of the clinical files of patients followed in our Hospital and diagnosed with cerebral creatine deficiency syndrome. Results: Twelve patients belonging to seven different families were diagnosed with creatine deficiency syndromes. Five presented GAMT deficiency and seven CT1 deficiency. Present ages are 2 to 38 years old. The most common clinical presentations were: global development delay in seven patients (two with epilepsy), and speech delay in two patients. Only one patient had communication and social interaction dysfunction. In all, global development delay in the range of intellectual delay was identified. The pathognomonic pattern of cerebral creatine deficiency in the brain image was demonstrated in eight patients. Pathogenic mutations in GAMT or SLC6A8 genes were identified in all cases. Conclusions: The suspicion of cerebral creatine depletion must be considered in all children presenting unexplained global psychomotor development delay. Pre-symptomatic therapy has shown promising results, especially in GAMT deficiency patients. The high rate of asymptomatic carriers of GAMT mutations in our population makes this disorder eligible to neonatal screening in Portugal.por
dc.identifier.citationActa Med Port. 2012;25(6):389-98por
dc.identifier.urihttp://hdl.handle.net/10400.4/1529
dc.language.isoporpor
dc.peerreviewedyespor
dc.subjectCérebropor
dc.subjectCreatininapor
dc.subjectDoenças Genéticas Ligadas ao Xpor
dc.subjectEncefalopatias Metabólicas Congénitaspor
dc.titleSíndromes de Deficiência Cerebral de Creatinapor
dc.title.alternativeCerebral Creatine Deficiency Syndromespor
dc.typejournal article
dspace.entity.typePublication
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cerebral Creatine Deficiency Syndromes.pdf
Size:
282.97 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections